Company profile
Synergy CHC Corp.
NASDAQ: SNYR · Healthcare · Medical - Distribution
#504 of 1,418 Healthcare companies by revenue31st-percentile growth
EA Score
35DFH 33DQ 29GM 48SS 44
v0.1 · 65/100 weight · provisional
↑ growth stability, operating margin · ↓ Piotroski F, filing timeliness
Methodology →Revenue TTM
$27.7M
Rev growth YoY (TTM)
-17.5%
Net income (FY)
-$12.3M
Employees
28
as of 2026-08-25
Market cap
$1.1M
as of 2026-08-25
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$30.4M$30.4M2025
Net income-$12.3M-$12.3M2025
Operating income-$8.5M-$8.5M2025
Total assets$10.2M$10.2M2025
Liabilities$33.3M$33.3M2025
Equity-$23.1M-$23.1M2025
Revenue trend
FY2015 – FY2025 · USD
FY15
FY16
FY18
FY18
FY19
FY24
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Retail100%
By geography
UNITED STATES90%
CANADA8%
MEXICO2%
Other Member0%
The read
What is Synergy CHC Corp.’s revenue?
Synergy CHC Corp. booked $30.4M in FY2025 revenue, contracting 13% year over year — slower than 69% of Healthcare companies we track, at a -40.6% net margin.
Peers · Healthcare
BioSyent Inc.83B+STRATA Skin Sciences, Inc.52DYourWay Cannabis Brands Inc.——Scilex Holding Company28DDelota Corp.——IMRIS Inc.——Neighbors
Cumberland →Key facts
CEOJack Ross
SectorHealthcare
IndustryMedical - Distribution
HeadquartersWestbrook, ME
ExchangeNASDAQ: SNYR
Employees28
IPO date2014-03-17
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.